Infectious Diseases News and Research

RSS

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

FDA grants traditional approval for Fuzeon (enfuvirtide), to treat HIV

Roche and Trimeris today announced that the U.S. Food and Drug Administration (FDA) has granted traditional approval to Fuzeon (enfuvirtide), the first and only fusion inhibitor for the treatment of HIV.

18 Oct 2004

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Researchers from the Harvard School of Public Health have discovered what they believe is the fundamental mechanism within cells that links two fast-rising public health threats: obesity and Type 2 diabetes.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

SARS survivor to share his personal and professional experience of SARS

A Hong Kong SARS survivor who helped lead the territory's response to the disease from his hospital bed will be sharing his personal and professional experience of SARS at an international conference in Wellington next month.

13 Oct 2004

Infections among injecting drug users are a growing public health concern in the UK

New figures published by the UK's Health Protection Agency show that infections among injecting drug users (IDUs) are a growing public health concern.

13 Oct 2004

New study offers rare glimpse of how the smallpox virus attacks its victims

Results of a new study in monkeys offer scientists a rare glimpse of how, on a molecular level, the smallpox virus attacks its victims. The findings shed light on how the virus caused mass death and suffering, and will help point the way to new diagnostics, vaccines and drugs that would be needed in the event of a smallpox bioterror incident.

12 Oct 2004

Plea for every human to have access to safe drinking water

A plea to the world's physicians and health authorities to do more to support measures to provide access to safe drinking water at low cost to every human on the planet has been made by the World Medical Association.

12 Oct 2004

Immune responses to airborne fungi could cause the stuffy noses and airway inflammation among sufferers of chronic rhinosinusitis

A team led by Mayo Clinic researchers has determined that over-reactive immune responses to airborne fungi could cause the stuffy noses and airway inflammation among sufferers of chronic rhinosinusitis.

10 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Expert says it is unlikely bird flu will reach Canada

United Nations officials warn the outbreak of bird flu is far from over and continues to spread in Thailand and Vietnam. An expert at The University of Western Ontario says it is unlikely the disease will reach Canada but travellers should take precautions.

5 Oct 2004

Significant progress in development of an animal model of smallpox that closely resembles human disease

Scientists have made significant progress in developing an animal model of smallpox that closely resembles human disease, which will be necessary for testing of future vaccines and potential treatments.

5 Oct 2004

Health expert has hails Hong Kong's work to fight SARS both locally and overseas

"Hong Kong has made good progress in preparing itself against communicable diseases and its effort was commendable. I am particularly pleased to see that the Centre for Health Protection has got off to a very good start and is set to become a public icon for health protection," he said.

5 Oct 2004

A new study shows that sick children can go home from the hospital more quickly

A new study shows that sick children can go home from the hospital more quickly, less expensively and with less chance of a repeat visit if children's hospitals use a unique source of national data to check their performance against other children's hospitals and show them where they can improve.

5 Oct 2004

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

The National Institutes of Health (NIH) announced today that it plans to award about $75 million over five years to five clinical centers and a data coordinating center to conduct studies of islet transplantation in patients with type 1 diabetes.

4 Oct 2004

Giving flu vaccine to toddlers in the spring and fall guards against infection

Giving flu vaccine to toddlers in the spring and fall guards against infection and is easier on parents than the fall schedule of two doses administered a month apart, found researchers from Duke University Medical Center and the University of Washington.

4 Oct 2004

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

The National Institutes of Health (“NIH”) has selected The Burnham Institute to develop a national resource for medical researchers to be known as the “Center on Proteolytic Pathways”.

4 Oct 2004

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims’ bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length.

30 Sep 2004

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).

30 Sep 2004

Drug-resistant bacteria increasingly causing infections in healthy people

An emerging form of so-called "flesh-eating bacteria" is caused by a strain that is resistant to standard first-line antibiotics. The same type of bacteria, methicillin-resistant Staphylococcus aureus (MRSA) is causing record numbers of less-serious skin infections in children and also is emerging as a cause of pneumonia, which can be deadly

30 Sep 2004

Infectious Diseases News and Research

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

FDA grants traditional approval for Fuzeon (enfuvirtide), to treat HIV

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Malaria vaccine candidate looks extremely promising

SARS survivor to share his personal and professional experience of SARS

Infections among injecting drug users are a growing public health concern in the UK

New study offers rare glimpse of how the smallpox virus attacks its victims

Plea for every human to have access to safe drinking water

Immune responses to airborne fungi could cause the stuffy noses and airway inflammation among sufferers of chronic rhinosinusitis

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Expert says it is unlikely bird flu will reach Canada

Significant progress in development of an animal model of smallpox that closely resembles human disease

Health expert has hails Hong Kong's work to fight SARS both locally and overseas

A new study shows that sick children can go home from the hospital more quickly

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

Giving flu vaccine to toddlers in the spring and fall guards against infection

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Drug-resistant bacteria increasingly causing infections in healthy people

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News